News|Podcasts|July 30, 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Kevin Chen, PharmD, MS, BCOP, CPP; and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the newly approved drug taletrectinib.


Latest CME